Masimo Corporation (NASDAQ:MASI) Given Consensus Rating of “Hold” by Analysts

Shares of Masimo Corporation (NASDAQ:MASI) have received a consensus rating of “Hold” from the eight analysts that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $189.40.

MASI has been the topic of a number of recent analyst reports. Zacks Research lowered shares of Masimo from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 24th. Bank of America began coverage on shares of Masimo in a report on Monday, November 17th. They set a “neutral” rating and a $162.00 price objective on the stock. BTIG Research raised their target price on Masimo from $198.00 to $200.00 and gave the stock a “buy” rating in a research note on Thursday, December 4th. Needham & Company LLC reiterated a “hold” rating on shares of Masimo in a research note on Monday, December 1st. Finally, Wall Street Zen raised Masimo from a “hold” rating to a “buy” rating in a report on Tuesday, October 14th.

Masimo Stock Up 1.6%

MASI stock traded up $2.18 on Friday, hitting $142.05. 863,953 shares of the company’s stock were exchanged, compared to its average volume of 639,104. The firm has a 50 day moving average price of $139.25 and a two-hundred day moving average price of $146.11. Masimo has a 12-month low of $125.94 and a 12-month high of $194.88. The stock has a market cap of $7.63 billion, a P/E ratio of -13.48, a price-to-earnings-growth ratio of 1.45 and a beta of 1.26. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.92 and a current ratio of 2.84.

Masimo (NASDAQ:MASI) last issued its quarterly earnings results on Tuesday, November 4th. The medical equipment provider reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.12. Masimo had a positive return on equity of 33.04% and a negative net margin of 33.20%.The business had revenue of $371.20 million during the quarter, compared to the consensus estimate of $366.89 million. During the same quarter last year, the company earned $0.86 earnings per share. The company’s quarterly revenue was up 8.2% on a year-over-year basis. Masimo has set its FY 2025 guidance at 5.620-5.790 EPS. As a group, equities research analysts expect that Masimo will post 4.1 EPS for the current fiscal year.

Institutional Trading of Masimo

Several institutional investors and hedge funds have recently bought and sold shares of the business. MAI Capital Management increased its stake in shares of Masimo by 176.7% in the second quarter. MAI Capital Management now owns 202 shares of the medical equipment provider’s stock worth $34,000 after acquiring an additional 129 shares during the period. Hilltop National Bank purchased a new stake in Masimo in the second quarter valued at $37,000. Smartleaf Asset Management LLC grew its position in Masimo by 80.0% during the 3rd quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 136 shares during the period. Advisory Services Network LLC purchased a new position in shares of Masimo during the 3rd quarter valued at about $46,000. Finally, Danske Bank A S acquired a new position in shares of Masimo in the 3rd quarter valued at about $59,000. 85.96% of the stock is currently owned by institutional investors and hedge funds.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.